Profound Medical Corp.
PROF- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001628808
No open-market purchases or sales by Profound Medical Corp. insiders were filed in the last 90 days; 55 institutions reported holding it in 13F filings for Q2 2026, worth $105.8M in total; no superinvestor holds it.
Q2 2023 vs. Q1 2023
How the institutions holding Profound Medical Corp. changed between Q1 2023 and Q2 2023.
All holders in Q2 2023All holders in Q1 2023
| Measure | Q1 2023 | Q2 2023 | Change |
|---|---|---|---|
| Holders | 32 | 33 | +1 |
| Shares | 7.73M | 7.64M | −91.3K (−1.2%) |
| Value | $71.7M | $98.7M | +$27.0M (+37.7%) |
New holders (3)
Institutions that held Profound Medical Corp. at the end of Q2 2023 but not at the end of Q1 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Goldman Sachs Group Inc | 16,700 | $217.3K | 0.00% |
| Citadel Advisors LLC | 12,194 | $158.6K | 0.00% |
| Simplex Trading, LLC | 142 | $1.00K | 0.00% |
Sold out (2)
Institutions that held Profound Medical Corp. at the end of Q1 2023 and filed for Q2 2023 without it.
| Institution | Shares, Q1 2023 | Value, Q1 2023 |
|---|---|---|
| Jane Street Group, LLC | 17,453 | $162.1K |
| Belpointe Asset Management LLC | 186 | $1.73K |